Literature DB >> 8953109

Characterization of indole-negative Bacteroides fragilis group species with use of polymerase chain reaction fingerprinting and resistance profiles.

M C Claros1, D M Citron, S Hunt Gerardo, E J Goldstein, G Schönian, T Montag, B Hampel, A C Rodloff.   

Abstract

Biochemical tests alone do not adequately differentiate the various Bacteroides species, groups, and antimicrobial-resistant variants. Consequently, we used a polymerase chain reaction (PCR) fingerprinting technique, with either a single nonspecific primer derived from the t-DNA intergenic spacer region (T3B) or a single primer that anneals to minisatellite DNA sequences (M13 core), to identify and characterize 58 clinical isolates of Bacteroides fragilis group species (B. fragilis, B. distasonis, and B. caccae). In addition to species- and subspecies-specific differences, 4 strains of B. fragilis, 1 of B. distasonis, and 3 of B. caccae that showed increased resistance to imipenem, ampicillin, and ampicillin/sulbactam also produced unique PCR fingerprint profiles. Analysis by the clinical source of isolation (i.e. blood or intraabdominal, skin, or soft-tissue infection) indicated that no particular PCR fingerprint type was associated with greater pathogenicity of any individual clinical source. The PCR fingerprinting technique proves to be a useful tool for species identification and taxonomic studies, as well as for epidemiological studies of Bacteroides species.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8953109     DOI: 10.1093/clinids/23.supplement_1.s66

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  In vitro activities of gatifloxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteria.

Authors:  R Schaumann; G Ackermann; B Pless; M C Claros; A C Rodloff
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

2.  Comparative in vitro activities of gemifloxacin, other quinolones, and nonquinolone antimicrobials against obligately anaerobic bacteria.

Authors:  N Kleinkauf; G Ackermann; R Schaumann; A C Rodloff
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Cross-infection due to imipenem-resistant Bacteroides fragilis associated with a totally implantable venous port.

Authors:  Corinne Arpin; Véronique Dubois; Anne-Marie Rogues; Fanny Menard; Anne-Marie Gavinet; Jean-Pierre Maire; Jean-Pierre Gachie; Marie-Christine Bezian; Claudine Quentin
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

4.  Pasteurella multocida subsp. multocida and P. multocida subsp. septica differentiation by PCR fingerprinting and alpha-glucosidase activity.

Authors:  S Hunt Gerardo; D M Citron; M C Claros; H T Fernandez; E J Goldstein
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

5.  Characterization of Bacteroides forsythus strains from cat and dog bite wounds in humans and comparison with monkey and human oral strains.

Authors:  M K Hudspeth; S Hunt Gerardo; M F Maiden; D M Citron; E J Goldstein
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  Characterization of saccharolytic Bacteroides and Prevotella isolates from infected dog and cat bite wounds in humans.

Authors:  C J Alexander; D M Citron; S Hunt Gerardo; M C Claros; D Talan; E J Goldstein
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

7.  First isolation of Bacteroides thetaiotaomicron from a patient with a cholesteatoma and experiencing meningitis.

Authors:  Lionel Feuillet; Joseph Carvajal; Isabelle Sudre; Jean Pelletier; Jean Marc Thomassin; Michel Drancourt; André Ali Cherif
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

8.  Antimicrobial Resistance Profile and Nim Gene Detection among Bacteroides fragilis Group Isolates in a University Hospital in South India.

Authors:  Shashidhar Vishwanath; Padmaja Ananth Shenoy; Kiran Chawla
Journal:  J Glob Infect Dis       Date:  2019 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.